In this exclusive MedPage Today video, Specht is joined via Zoom by study co-lead, Heather Jacene, MD, of Brigham and Women's ...

Liv Hospital integrates PET/CT diagnostics, radionuclide therapies and a multidisciplinary council to create individualized treatment plans for complex cancer and cardiac cases.

Staging locally advanced breast cancer patients with 18 F-labeled fluorodeoxyglucose (FDG) PET-CT detected more distant metastases -- and thus reduced the number of patients who received combined ...

PET scans may serve as both a diagnostic and prognostic tool in giant cell arteritis (GCA), according to a new study. In over 100 patients with GCA who underwent 18 F-fluorodeoxyglucose (FDG) PET ...

Vancouver, British Columbia, Canada (Embargoed until 3:15 p.m. PDT, Saturday, June 11, 2022)— 18 F-FDG PET/CT has been proven successful in evaluating lung inflammation and monitoring treatment ...

Use of gene expression of specific marker genes in intraperitoneal lavage samples to predict peritoneal dissemination in gastric carcinoma. Methods: 24 patients with esophageal squamous cell carcinoma ...

Ovarian Cancer (OC) is the leading cause of gynecologic cancer–related deaths and the fifth most frequent cause of cancer mortality in women (5%) following lungs (25%), colon-rectum (14%), breast (8%) ...

Total body PET/CT scans can successfully visualize systemic joint involvement in patients with autoimmune arthritis, according to new first-in-human research published in the October issue of The ...

Fluorodeoxyglucose (FDG) has proven benefits as a positron emission tomography (PET) radiopharmaceutical in oncology. However, it has limitations in the assessment of certain tumours, above all (but ...

No significant financial relationships to disclose. This is an ASCO Meeting Abstract from the 2009 ASCO Annual Meeting I. This abstract does not include a full text component.